A3 TARGETING PROLINE METABOLISM TO OVERCOME TREATMENT RESISTANCE IN ESOPHAGEAL CANCER

BACKGROUND: Patients with esophageal malignancy have a 5-year survival rate of only 14% in Canada. This high mortality rate is due to three factors: late diagnosis, difficulty to surgically remove the tumor due to its localization and treatment resistance. Treatment resistance has been ascribed to t...

Descripción completa

Detalles Bibliográficos
Autores principales: Douchin, J, Nogueira de Almeida, L, Gonneaud, A, Boisvert, F, Dufour, A, Giroux, V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Oral Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859203/
http://dx.doi.org/10.1093/jcag/gwab049.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859203/
http://dx.doi.org/10.1093/jcag/gwab049.002

Ejemplares similares